Acorah Software Products - Accounts Production16.2.850falsetruefalsetrueNo description of principal activity15 March 202431 March 202531 March 202515564382Dr Laura-Ann Hamiltoniso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure155643822024-03-14155643822025-03-31155643822024-03-152025-03-3115564382frs-core:CurrentFinancialInstruments2025-03-3115564382frs-bus:PrivateLimitedCompanyLtd2024-03-152025-03-3115564382frs-bus:FilletedAccounts2024-03-152025-03-3115564382frs-bus:Micro-entities2024-03-152025-03-3115564382frs-bus:AuditExempt-NoAccountantsReport2024-03-152025-03-3115564382frs-bus:Director12024-03-152025-03-31
Registered number: 15564382
Dr Laura-Ann McGill Ltd
Unaudited Financial Statements
For the Period 15 March 2024 to 31 March 2025
Sharpe Medical Accounting Ltd
Dr Laura-Ann McGill Ltd
Balance Sheet
As At 31 March 2025
Balance Sheet
Registered number: 15564382
31 March 2025
£
Current assets
4,074
Creditors: Amounts Falling Due Within One Year
(1,832)
NET CURRENT ASSETS
2,242
TOTAL ASSETS LESS CURRENT LIABILITIES
2,242
Accruals and deferred income
(480)
NET ASSETS
1,762
CAPITAL AND RESERVES
1,762
Notes
1.General Information
Dr Laura-Ann McGill Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15564382. The registered office is 39 Elm Grove Road, London, SW13 0BU.
2.Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.